Condition: Perennial Allergic Rhinitis · Seasonal Allergic Rhinitis · Local Allergic Rhinitis · Sponsor: Universitaire Ziekenhuizen KU Leuven
This prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy. The NAPT will take place before, during and after AIT to evaluate the cost and effectiveness of the treatment. The study consists of 4 visits and 2 telephone contacts that are repeated annually for 3 years. This study will be conducted in 2 hospitals: UZ Leuven and AZ ST. Jan Brugge on the consultation Ear, Nose and Throat Diseases (ENT) and the department of Internal Medicine / Allergology
This description comes directly from the study's public registry record.
Margot Vandekerckhove · +3216332342 · margot.vandekerckhove@uzleuven.be
Laura Van Gerven, PhD · +3216336340 · laura.vangerven@uzleuven.be
Always discuss trial participation with your own doctor first.
| UZ Leuven | Leuven, Vlaam Brabant, Belgium | Recruiting |
| AZ Sint-Jan | Bruges, Belgium | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04544774